Skip to main content

Published locations for FDA Approves Subcutaneous Bortezomib for Marketed Indications

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA Approves Subcutaneous Bortezomib for Marketed Indications

User login

  • Reset your password
  • /content/fda-approves-subcutaneous-bortezomib-marketed-indications
  • /oncologypractice/article/47231/lymphoma-plasma-cell-disorders/fda-approves-subcutaneous-bortezomib
  • /hematology-oncology/article/47231/lymphoma-plasma-cell-disorders/fda-approves-subcutaneous